Neuroinflammatory Hypotheses of Depression

Tuesday, December 13, 2016
Neuroinflammatory Hypotheses of Depression

In this month's webinar, Dr. Yvette I. Sheline will explain neuroinflammatory hypotheses of depression and PTSD treatment.

Webinar Recording:


Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.

Sign up for upcoming webinars.

View other past webinar recordings.

Presented by 
Yvette I. Sheline, M.D.
Yvette I. Sheline, M.D.
University of Pennsylvania Perelman School of Medicine

McLure Professor Of Psychiatry And Behavioral Research

Director, Center for Neuromodulation in Depression and Stress (CNDS)

Scientific Council Member (Joined 2013)

2005, 2002 Independent Investigator Grants

 

Dr. Yvette Sheline is known for her pioneering studies of hippocampal volume loss in major depression and the moderating effects of antidepressant treatment, work widely cited in psychiatric literature. Her research has also integrated structural/functional neuroimaging with depression course, neuropsychological correlates, and treatment outcomes. She seeks to determine how depression affects the brain using neuroimaging techniques, and to understand how stress produces functional dysregulation. Dr. Sheline investigates treatment effects of antidepressants and cognitive behavioral therapy on emotion-induced fMRI activity in PTSD and depression; longitudinal effects of treatment on neuropsychological and brain structural variables in late-life depression; and modifiers of brain amyloid binding in normal aging and preclinical Alzheimer’s Disease.

Prior to joining the faculty at Penn, Dr. Sheline was Professor of Psychiatry and Director, Center for Depression Stress and Neuroimaging at Washington University School of Medicine in St. Louis.

Moderated by
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation
 

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association.

Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.